Online Program Home
My Program

Abstract Details

Activity Number: 273 - How Advanced Analytic Tools Deliver Insights for Clinical Investigations Through Real World Data
Type: Invited
Date/Time: Tuesday, July 30, 2019 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract #300166
Title: Analytic Strategies of Using Propensity Scores in Clinical Data Augmentation
Author(s): Junjing Lin* and Margaret Gamalo-Siebers and Ram Tiwari
Companies: AbbVie and Eli Lilly and CDRH, FDA
Keywords: propensity scores; data augmentation; causal inference; historical control; real world data; electronic health records

To obtain marketing approval of a therapeutic product, the statutes require manufactures to demonstrate substantial evidence of effectiveness through the conduct of adequate and well-controlled studies, i.e., the conduct of randomized controlled trials (RCTs). However, these trials are sometimes unfeasible due to their size, duration, cost, or ethical constraints. In this case, data derived from external registry can be useful to complement information provided by RCTs. With the increasing availability of electronic healthcare databases, identifying valid registry records to match with RCT data presents opportunities and challenges. In this talk, different data augmentation schemes based on propensity scores are explored.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2019 program